(Q38468383)

English

Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis

scientific article published on 09 May 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

1 reference

Europe PubMed Central

Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G Li

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Q Shen

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C Li

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Li

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M He

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

9 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

684-693

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Biomarkers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

New serum markers of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

New biomarkers and targets in pancreatic cancer and their application to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Human RISC couples microRNA biogenesis and posttranscriptional gene silencing

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

The long and short of microRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Circulating microRNAs: molecular microsensors in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

An integrative meta-analysis of microRNAs in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

miR-21-mediated tumor growth

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

Analysis of circulating microRNA: preanalytical and analytical challenges.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1294-Y

21 January 2018

MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNAs as biomarkers for hepatocellular carcinoma: a diagnostic meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating Diagnostic Accuracy from Multiple Conflicting Reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of circulating microRNAs for hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma miR-21: a potential diagnostic marker of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Expression of miRNA-29b and its clinical significances in primary hepatic carcinoma].

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25956842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-015-1294-Y

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38468383&oldid=2201741181"